Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bile Duct Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05150691
What this trial is testing

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

Who this might be right for
HER2-positive Advanced Solid Tumor
DualityBio Inc. 796
Large-scale testing (Phase 3)Ended earlyNCT00387348
What this trial is testing

Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer

Who this might be right for
Colorectal CancerDepressionEsophageal Cancer+7 more
Massachusetts General Hospital 24
Not applicableLooking for participantsNCT03978078
What this trial is testing

A Clinicobiological Database in Metastatic Digestive Cancers

Who this might be right for
Digestive System Neoplasm
Institut du Cancer de Montpellier - Val d'Aurelle 200
Not applicableUnknownNCT01926717
What this trial is testing

A Comparative Clinical Research on Single Roux-en-Y and Traditional Roux-en-Y of Pancreaticojejunostomy-choledochojejunostomy For Treatment of Obstruction of Pancreatic Duct and Bile Duct

Who this might be right for
Pancreatic Cancer
Chengyi Sun 100
Not applicableUnknownNCT01549795
What this trial is testing

Liver Transplantation for Hilar Cholangiocarcinoma in Association With Neoadjuvant Radio- and Chemo-therapy

Who this might be right for
Hilar CholangiocarcinomaPrimary Sclerosing Cholangitis
Azienda Ospedaliera di Padova 33
Not applicableStudy completedNCT06888401
What this trial is testing

Clinico-demographic Profile of the Patient With Pancreaticobiliary Malignancy Undergoing ERCP in a Tertiary Care Center of Nepal

Who this might be right for
CholangiocarcinomaBile Duct CarcinomaEndoscopic Retrograde Cholangio-Pancreatography+1 more
Kathmandu University School of Medical Sciences 597
Testing effectiveness (Phase 2)Study completedNCT03231176
What this trial is testing

Varlitinib Plus Capecitabine in Chinese Patients With Advanced or Metastatic Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
ASLAN Pharmaceuticals 62
Testing effectiveness (Phase 2)Study completedNCT00004910
What this trial is testing

Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction

Who this might be right for
Colorectal CancerConstipation, Impaction, and Bowel ObstructionExtrahepatic Bile Duct Cancer+6 more
Northwestern University
Testing effectiveness (Phase 2)Ended earlyNCT01096745
What this trial is testing

Randomized Trial of Gemcitabine/Cisplatin Versus S-1/Cisplatin in Advanced Biliary Cancer

Who this might be right for
Metastatic Biliary Tract CancerLocally Advanced Biliary Tract Cancer
Gyeongsang National University Hospital 78
Not applicableLooking for participantsNCT06877637
What this trial is testing

On-treatment Surveillance of Tumor Evolution and Response to Systemic Treatment in Bile Duct and Liver Cancer

Who this might be right for
Hepatocellular Carcinoma (HCC)Cholangiocarcinoma
Region Skane 150
Not applicableUnknownNCT01438385
What this trial is testing

Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders

Who this might be right for
Ampullary CancerDuodenal CancerBile Duct Cancer+20 more
Weill Medical College of Cornell University 12,000
Not applicableStudy completedNCT05434520
What this trial is testing

Relieving the Bile Ducts Prior to Pancreatoduodenectomy

Who this might be right for
Pancreas CancerSurgery-ComplicationsBiliary Fistula
Rigshospitalet, Denmark 722
Testing effectiveness (Phase 2)Study completedNCT03058289
What this trial is testing

A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6

Who this might be right for
Breast CancerHead and Neck CancerSquamous Cell Carcinoma+8 more
Intensity Therapeutics, Inc. 111
Testing effectiveness (Phase 2)UnknownNCT02836847
What this trial is testing

Molecularly Target Therapy With GEMOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

Who this might be right for
Cholangiocarcinoma of the Extrahepatic Bile DuctGallbladder Cancer
Shanghai Jiao Tong University School of Medicine 152
Testing effectiveness (Phase 2)Study completedNCT00005938
What this trial is testing

DX-8951f in Treating Patients With Biliary Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
Daiichi Sankyo
Early research (Phase 1)Study completedNCT02375880
What this trial is testing

Study of DKN-01 and Gemcitabine/Cisplatin in Patients With Carcinoma to Primary to the Intra- or Extra-Hepatic Biliary System or Gallbladder

Who this might be right for
Carcinoma of Intrahepatic and Extra-hepatic Biliary SystemCarcinoma of GallbladderBile Duct Cancer+1 more
Leap Therapeutics, Inc. 51
Very early researchStudy completedNCT00902759
What this trial is testing

Fatigue and Pancreas and Bile Duct Cancer Study

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 100
Testing effectiveness (Phase 2)Study completedNCT03230318
What this trial is testing

Derazantinib in Subjects With FGFR2 Gene Fusion-, Mutation- or Amplification- Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic CholangiocarcinomaCombined Hepatocellular and Cholangiocarcinoma
Basilea Pharmaceutica 148
Testing effectiveness (Phase 2)Ended earlyNCT04566133
What this trial is testing

Combination of Trametinib (MEK Inhibitor) and Hydroxychloroquine (HCQ) (Autophagy Inhibitor) in Patients With KRAS Mutation Refractory Bile Tract Carcinoma (BTC).

Who this might be right for
Bile Duct CancerBiliary CancerBiliary Tract Neoplasms+1 more
National Cancer Institute (NCI) 2
Large-scale testing (Phase 3)WithdrawnNCT01622803
What this trial is testing

Comparison Between Two Methods of Bilateral Stenting for Malignant Hilar Obstruction

Who this might be right for
Bile Duct NeoplasmObstructive Jaundice
Samsung Medical Center
Next Page